There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:C07K16/40
Subcategories
This category has the following 11 subcategories, out of 11 total.
B
D
N
R
S
T
Y
Pages in category "C07K16/40"
The following 20 pages are in this category, out of 20 total.
1
- 18290730. DE-CLUSTERING INHIBITORS OF PTPRA (The Regents of the University of California)
- 18359569. LDL RECEPTOR-DIRECTED BISPECIFIC BINDING AGENT-LIGAND FUSIONS FOR THE DEGRADATION OF TARGET PROTEINS simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18384176. INHIBITING ANTI-ENPP1 ANTIBODIES simplified abstract (The Regents of the University of California)
- 18548481. TARGETING T REGULATORY CELLS TO ISLET CELLS TO STALL OR REVERSE TYPE 1 DIABETES simplified abstract (The Trustees of the University of Pennsylvania)
- 18552141. SYNTHETIC INTERMEMBRANE PROTEOLYSIS RECEPTORS FOR CUSTOM ANTIGEN-INDUCED TRANSCRIPTIONAL REGULATION simplified abstract (The Regents of the University of California)
- 18594234. ANTI-CXCR5 ANTIBODIES AND COMPOSITIONS AND USES THEREOF simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18597797. ADAM6 MICE simplified abstract (Regeneron Pharmaceuticals, Inc.)
- 18693921. TUMOR-SPECIFIC BISPECIFIC IMMUNE CELL ENGAGER (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18728278. DEVELOPMENT OF NANOBODIES AS FIRST-IN-CLASS INHIBITORS FOR THE DENEDDYLATING ENZYME NEDP1 (Centre National De La Recherche Scientifique)
- 18776496. DISRUPTING TUMOR TISSUES BY TARGETING FIBROBLAST ACTIVATION PROTEIN (FAP) (The Trustees of the University of Pennsylvania)
- 19009000. ANTI-FIBROTIC SIALIDASE INHIBITOR COMPOUNDS AND METHODS OF USE (THE TEXAS A&M UNIVERSITY SYSTEM)
B
T
- The regents of the university of california (20240294657). INHIBITING ANTI-ENPP1 ANTIBODIES simplified abstract
- The regents of the university of california (20250092156). DE-CLUSTERING INHIBITORS OF PTPRA
- The regents of the university of california (20250145733). TUMOR-SPECIFIC BISPECIFIC IMMUNE CELL ENGAGER
- The Regents of the University of California patent applications on March 20th, 2025
- THE REGENTS OF THE UNIVERSITY OF CALIFORNIA patent applications on May 8th, 2025
- The Regents of the University of California patent applications on September 5th, 2024